Brisbane Clinical Trials

The Filter Study

The study drug is a potential new treatment for a type of pulmonary hypertension due to heart failure.

2 nights
7 visits

The purpose of this study is to investigate a potential treatment for a specific type of pulmonary hypertension caused by heart failure, which results in high blood pressure in the lungs. The hearts of patients with this condition are less able to pump sufficient blood around the body, causing the body to increase the blood pressure in the lungs.

The study drug is made up of Relaxin, which is a hormone that is naturally produced by the body to relax blood vessels and lower blood. This study will be assessing the rate at which the kidneys are filtering blood.

The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Male or female of non-childbearing potential
Age 18 – 55 years old
BMI 18 – 32 kg/m²
Medical History No significant medical history
Medication Not taking any prescription medication
Smoking History Non-smokers or social smokers (<10 cigarettes/week)